ID   GM1-1019-SV
AC   CVCL_C0NY
SY   GM-1019-SV
DR   Wikidata; Q112929587
RX   PubMed=2990594;
RX   PubMed=3027449;
CC   Population: Japanese.
CC   Doubling time: ~20 hours (PubMed=2990594).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; SV40 large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84739; GM1 gangliosidosis
DI   ORDO; Orphanet_354; GM1 gangliosidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0NX ! GM1-1019
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
RX   PubMed=2990594; DOI=10.1007/BF01119596;
RA   Momoi T., Furuya T., Suzuki Y., Sato H., Yamaguchi N.;
RT   "In vitro establishment of human fibroblasts of lysosomal diseases,
RT   GM1-gangliosidosis and Sandhoff disease, by transformation with
RT   origin-minus SV40 DNA.";
RL   Biosci. Rep. 5:267-273(1985).
//
RX   PubMed=3027449; DOI=10.1007/BF01819299;
RA   Furuya T., Momoi T., Suzuki Y., Sato H., Yamaguchi N.;
RT   "Establishment of human fibroblast cell lines with lysosomal enzyme
RT   deficiency by transformation with origin-minus SV40 DNA.";
RL   J. Inherit. Metab. Dis. 8:143-144(1985).
//